Triple Negative Breast Cancer Trial
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Carboplatin|DRUG: Docetaxel
Sponsor: Institute of Cancer Research, United Kingdom
Collaborators: King's College London|Cancer Research UK|Breakthrough Breast Cancer